For the latest period, Johnson & Johnson has a gross margin of 67.9%, an operating margin of 26.5%, an EBITDA margin of 34.7%, and a net margin of 21.5%. The biggest positive change was in operating margin, increasing 2.8 percentage points. The biggest negative change was in EBITDA margin, decreasing 4.6 percentage points.
Johnson & Johnson's margins averaged 68.63% gross, 25.12% operating, 43.12% EBITDA, and 29.71% net during the last 3 years. Current figures show operating margin is above its three-year average, while gross, EBITDA, and net margins are below their three-year averages.
operating margin expanded by 2.8 percentage points, but EBITDA margin contracted by 4.6 percentage points and net margin by 3.5 percentage points.
Over the last 3 years, Johnson & Johnson's gross margin averaged 68.63%. The current gross margin of 67.9% is 0.7 percentage points below its three-year average. During this period, gross margin reached a high of 70.3% in Oct 2023 and a low of 67.8% in Mar 2026.
The average operating margin for Johnson & Johnson was 25.12% during the last 3 years. At present, the current operating margin for Johnson & Johnson is 26.5%, 1.4 percentage points above its three-year average. The operating margin for Johnson & Johnson moved between 23.4% in Dec 2024 and 26.8% in Dec 2025.
The average EBITDA margin for Johnson & Johnson was 43.12% during the last 3 years. Johnson & Johnson currently reports an EBITDA margin of 34.7%, 8.4 percentage points below its three-year average. The EBITDA margin for Johnson & Johnson moved between 27.9% in Dec 2024 and 58% in Oct 2023.
Johnson & Johnson's net margin averaged 29.71% during the last 3 years. Compared with its three-year average, Johnson & Johnson's current net margin is 21.5% and is 8.2 percentage points below its three-year average. Over the last 3 years, Johnson & Johnson's net margin peaked at 45.4% in Oct 2023 and reached a low of 15.8% in Dec 2024.
Johnson & Johnson's gross margin of 67.9% is below the Healthcare sector, the industry and its peers average. But in comparison with its Healthcare sector average of 68.5%, Johnson & Johnson's gross margin is only 0.9% lower.
For the period ending Jun 28, 2026, JNJ recorded a gross margin of 67.9%.
The current operating margin for JNJ is 26.5% as of Jun 28, 2026.
As of Jun 28, 2026, JNJ has an EBITDA margin of 34.7%.
For the period ending Jun 28, 2026, JNJ recorded a net margin of 21.5%.
Johnson & Johnson's gross, operating, EBITDA, and net margins averaged 68.6% gross, 25.1% operating, 43.1% EBITDA, and 29.7% net over the last 3 years.
In the last 5 years, the highest margins reported by JNJ were 70.3% gross in Oct 2023, 26.8% operating in Dec 2025, 58% EBITDA in Oct 2023, and 45.4% net in Oct 2023.
Over the last 5 years, Johnson & Johnson's lowest margins were 67.5% gross in Oct 2021, 23.4% operating in Jul 2022, 27.9% EBITDA in Dec 2024, and 15.8% net in Dec 2024.